CHAPTER 125
HB 157 - FINAL VERSION
8Mar2017... 0682h
2017 SESSION
17-0114
01/09
HOUSE BILL 157
AN ACT adding chronic pain to qualifying conditions under therapeutic use of cannabis.
SPONSORS: Rep. Schleien, Hills. 37; Rep. E. Edwards, Hills. 11; Rep. Fisher, Belk. 9; Rep. Zaricki, Hills. 6; Rep. Josephson, Graf. 11
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
This bill establishes chronic pain as a qualifying medical condition under therapeutic use of cannabis.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
8Mar2017... 0682h 17-0114
01/09
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Seventeen
AN ACT adding chronic pain to qualifying conditions under therapeutic use of cannabis.
Be it Enacted by the Senate and House of Representatives in General Court convened:
125:1 Use of Cannabis for Therapeutic Purposes; Definitions. Amend RSA 126-X:1, IX(a) to read as follows:
IX.(a)(1) "Qualifying medical condition'' means the presence of:
[(1)] (A) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and
[(2)] (B) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or
(2) "Qualifying medical condition" also means moderate to severe chronic pain.
125:2 Effective Date. This act shall take effect 60 days after its passage.
Approved: June 16, 2017
Effective Date: August 15, 2017
| Date | Body | Type |
|---|---|---|
| Jan. 25, 2017 | House | Hearing |
| Feb. 22, 2017 | House | Exec Session |
| March 8, 2017 | House | Floor Vote |
| April 11, 2017 | Senate | Hearing |
| April 20, 2017 | Senate | Floor Vote |
June 16, 2017: Signed by Governor Sununu 06/16/2017; Chapter 125; Eff. 8/15/2017
May 4, 2017: Enrolled 05/04/2017 HJ 15 P. 47
April 27, 2017: Enrolled (In recess 04/27/2017); SJ 16
April 20, 2017: Ought to Pass: RC 18Y-5N, MA; OT3rdg; 04/20/2017; SJ 14
April 20, 2017: Committee Report: Ought to Pass, 04/20/2017; SC 19
April 11, 2017: Hearing: 04/11/2017, Room 101, LOB, 01:45 pm; SC 18
March 9, 2017: Introduced 03/09/2017 and Referred to Health and Human Services; SJ 9
March 8, 2017: Ought to Pass with Amendment 0682h: MA RC 301-47 03/08/2017 HJ 9 P. 124
March 8, 2017: FLAM # 2017-0682h (Rep. J. MacKay): AA VV 03/08/2017 HJ 9 P. 124
: Minority Committee Report: Inexpedient to Legislate
March 8, 2017: Majority Committee Report: Ought to Pass for 03/08/2017 (Vote 12-6; RC)
Feb. 22, 2017: Executive Session: 02/22/2017 10:00 AM LOB 205
Jan. 25, 2017: Public Hearing: 01/25/2017 10:03 AM Representatives Hall
Jan. 4, 2017: Introduced 01/04/2017 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 18